By protecting it from contamination and environmental stress, you maximize both safety and value
The potency of PF-06882961 (CS EC 50 = 13 nM) on the cAMP pathway was approximately 120- and 14-fold (Fig 3A, Table S2) lower than exenatide (CS EC 50 = 0.11 nM) and liraglutide (CS EC 50 = 0.95 nM), respectively
Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel J-C, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG
Theories About Why Dual Action Works Better Scientists are still working to fully understand why adding GIP agonism to GLP-1 agonism creates such substantial additional benefits